GlassScriptPhysician profile
William G Patterson
NPI 1245346774
$3,289.07
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $1,843.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $465.23 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $358.62 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $286.46 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $269.54 | 2019-2020 | |
| Pfizer INC. | $239.32 | 2019-2020 | |
| Amarin Pharma, INC. | $197.98 | 2019-2020 | |
| Allergan, INC. | $170.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $169.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $146.98 | 2019 | |
| Lilly USA, LLC | $132.10 | 2019-2020 | |
| Astellas Pharma US INC | $122.26 | 2019-2020 | |
| Novo Nordisk INC | $101.59 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $89.04 | 2019-2020 | |
| Eisai INC. | $82.88 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.91 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $64.48 | 2019-2020 | |
| Esperion Therapeutics, INC. | $57.59 | 2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $49.26 | 2019 | |
| Glaxosmithkline, LLC. | $44.41 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.61 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $28.26 | 2020 | |
| Radius Health, INC. | $26.66 | 2019-2020 | |
| Aytu Biopharma, INC. | $19.62 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $17.82 | 2020 | |
| Antares Pharma, INC. | $16.46 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.21 | 2020 | |
| Ironwood Pharmaceuticals, INC | $12.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.